Evaluation for hospital discharge is being performed for a 67-year-old male recovering fro… — USMLE Step 2 CK

Evaluation for hospital discharge is being performed for a $67$ -year-old male recovering from community-acquired pneumonia. Upon initial admission $3$ days ago, he presented with a temperature of $39.1^\circ C$ ( $102.4^\circ F$ ), productive cough, and right lower lobe consolidation on chest radiography. Empiric treatment was initiated with intravenous ceftriaxone and azithromycin. Currently, he has been afebrile for $28$ hours, his respiratory rate is $16$ /min, and oxygen saturation is $96\%$ on room air. He is ambulating well and tolerating a regular diet. Blood cultures obtained at admission have finalized, growing *Streptococcus pneumoniae*. Antimicrobial susceptibility testing indicates the isolate is susceptible to penicillin (MIC $\leq 0.03 \mu$ g/mL), amoxicillin, ceftriaxone, levofloxacin, and linezolid. Based on these findings, which of the following is the most appropriate antimicrobial strategy for discharge?

Oral amoxicillinAnswer
B
Oral levofloxacin
C
Oral amoxicillin-clavulanate
D
Oral amoxicillin and oral azithromycin
E
Outpatient intravenous ceftriaxone

Answer

The most appropriate antimicrobial strategy is discharging the patient on oral amoxicillin.

The correct antimicrobial strategy is oral amoxicillin. This patient presented with community-acquired pneumonia and has now achieved clinical stability (afebrile, normal vitals, tolerating oral intake), indicating he is ready for transition to oral therapy. Blood cultures confirmed infection with *Streptococcus pneumoniae* that is highly susceptible to penicillin. In accordance with antimicrobial stewardship principles, empiric therapy (ceftriaxone and azithromycin) should be de-escalated to the most targeted, effective, and narrow-spectrum agent available. Oral amoxicillin has excellent bioavailability, effectively treats penicillin-susceptible pneumococcal infections, and minimizes unnecessary broad-spectrum exposure.

Step-by-Step Solution

Assess the patient's clinical stability for transition to oral therapy and hospital discharge.

The patient is afebrile for >24 hours, has normal vitals, and tolerates a regular diet, making him a candidate for an IV-to-PO antibiotic transition.

Current guidelines recommend transitioning to oral therapy when patients show clinical improvement and can tolerate oral intake.

Evaluate the culture and susceptibility results to guide targeted therapy.

Blood cultures grew Streptococcus pneumoniae that is highly susceptible to penicillin (MIC <= 0.03 mcg/mL) and amoxicillin.

Identifying the causative pathogen and its specific sensitivities allows for pathogen-directed, narrow-spectrum treatment.

Select the most appropriate, narrow-spectrum oral agent.

Oral amoxicillin is selected as the discharge medication.

Amoxicillin provides excellent oral bioavailability and narrow-spectrum coverage targeted specifically against penicillin-susceptible Streptococcus pneumoniae, adhering to core antimicrobial stewardship principles.

Key Concept

In clinically stable patients with community-acquired pneumonia who have positive cultures for penicillin-susceptible Streptococcus pneumoniae, empiric broad-spectrum therapy should be de-escalated to narrow-spectrum oral amoxicillin.

Alternative Method

In patients with a severe, IgE-mediated penicillin allergy, alternative targeted therapies for fully susceptible pneumococcus could include a respiratory fluoroquinolone (e.g., levofloxacin), despite its broader spectrum, to safely ensure clinical cure.

Estimated Time:1m 0s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Topics

More questions from this topic